bioMerieux

Industries Pharmaceuticals Biotechnology and Life Sciences
Subsidiaries Specific Diagnostics, Inc., Invisible Sentinel Inc., Astute Medical, Inc.

Rating Overview

Risk Rating: Medium

bioMerieux is Medium Risk.

bioMerieux is Medium Risk. The company often yields to political activism in shaping corporate governance, potentially alienating consumers, dividing employees, and harming shareholders. The company implements race and identity-based policies that replace merit, excellence, and integrity with preferential treatment and outcomes. The company occasionally embraces corporate initiatives that redirect its central focus from business goals to partisan policies and divisive issues at times. This approach fails to safeguard free exercise, free speech, and free enterprise.

Rating Criteria

Corporate Weaponization Risk Levels
Criteria Risk Level
Cancellations Medium Risk
Discriminatory Philanthropy Lower Risk
Employment Protection High Risk

Corporate Weaponization

Corporate Governance and Public Policy Risk Levels
Criteria Risk Level
Advocacy Bias High Risk
Funding Lower Risk
Political Actions Lower Risk

Corporate Governance and Public Policy

Rating Criteria Detail

Criteria Risk Level Rationale

Corporate Weaponization


Criteria:

Has canceled customers, suppliers, or vendors due to their political views or religious beliefs OR corporately boycotts, divests, or sanctions regions, people groups, or industries.

Risk Level:

Medium

Rationale:

bioMerieux integrates ESG into its business practices. From its Sustainable Procurement and Supplier Relations Charter: Suppliers must report on “the environment, for instance by taking into account issues associated with changes in fossil fuels, emissions pricing, energy consumption, raw materials, carbon footprints, waste management and lifecycle management” (1). The company ‘Global Supplier Code of Conduct’ requires international vendors to include sexual orientation in their nondiscrimination policy, promoting divisive sex and gender policies (2). However, the company has not publicly canceled customers, suppliers, or vendors based on political views or religious beliefs (3).

Criteria:

Charitable giving (including employee matching programs) policies or practices discriminate against charitable organizations based on views or religious beliefs.

Risk Level:

Lower

Rationale:

bioMerieux does not discriminate against charitable organizations based on views or beliefs (1)(2).

Criteria:

Employment policies fail to protect against viewpoint or other discrimination and/or are ideological in nature.

Risk Level:

High

Rationale:

bioMerieux appears to prioritize diversity over merit in its leadership composition. From its 2024 Universal Registration Document: “Accordingly, the Board of Directors has established a policy of promoting cultural and international diversity among its members;… aiming for gender equality” (1). The company does not provide viewpoint protections for its employees (2).

Corporate Governance and Public Policy


Criteria:

Uses corporate reputation to support causes, organizations, or policies hostile to freedom of expression.

Risk Level:

High

Rationale:

bioMerieux has “[integrated] the Company’s CSR ambitions into [its] corporate strategy” and claims Corporate Social Responsibility is its “DNA” (1). The company supports ESG within its business practices. From its 2024 Universal Registration Document: “This report is based on a double materiality approach, which takes into account both bioMérieux’s impact on the environment and society and the impact of environmental, social and governance (ESG) topics on the Company’s performance” (2).

Criteria:

Uses corporate funds to advance ideological causes, organizations, or policies hostile to freedom of expression.

Risk Level:

Lower

Rationale:

bioMerieux has not used corporate funds to advance ideological causes, organizations, or policies (1).

Criteria:

Uses corporate political actions and/or financial contributions for ideological, non-business purposes.

Risk Level:

Lower

Rationale:

bioMerieux does not operate a PAC at this time and has not used its lobbying for ideological purposes (1)(2)(3).